BPC-157/TB-500/KPV (Phoenix) Research Overview (also known as Phoenix Stack, BPC-157/TB-500/KPV Blend, Triple Repair Stack)

At a glance

Phoenix is a research blend of BPC-157, TB-500 and KPV that adds the anti-inflammatory tripeptide KPV to the Wolverine tissue-repair pair, studied for gut, skin and soft-tissue pathways.

What Is Phoenix Stack?

The Phoenix Stack is a synergistic triad composed of BPC-157, TB-500, and KPV. While BPC-157 and TB-500—collectively known as the "Wolverine" stack—provide a foundation for robust tissue repair, angiogenesis, and musculoskeletal recovery, the addition of KPV (a tripeptide derived from α-MSH) expands the protocol's scope. By integrating KPV, the stack provides systemic anti-inflammatory and mucosal healing coverage, specifically targeting gut health, skin integrity, and immune modulation.

The name "Phoenix" symbolizes comprehensive, full-body renewal. It is designed for complex recovery needs, including inflammatory injuries, IBD-adjacent support, and the management of systemic inflammatory loads. By combining the structural regenerative capabilities of BPC-157 and TB-500 with the targeted immunomodulatory effects of KPV, the stack offers a multi-pathway approach to recovery and systemic homeostasis.

Mechanism of Action

BPC-157 upregulates growth factors such as VEGF and EGF, promoting angiogenesis via nitric oxide modulation while protecting GI mucosa [L4]. TB-500 utilizes the LKKTET motif to sequester G-actin, facilitating the migration of fibroblasts and immune cells to injury sites to reduce scarring and accelerate tissue repair [L11]. KPV binds to MC1R and MC3R receptors, effectively downregulating NF-κB, IL-6, and TNF-α signaling while inhibiting mast cell degranulation and fostering epithelial healing [L8].

Together, these peptides operate through distinct, complementary pathways with no receptor competition, allowing for a highly coordinated response to both acute mechanical injury and chronic inflammatory states.

Structural Repair and Tissue Regeneration

The Phoenix Stack leverages the well-documented synergy between BPC-157 and TB-500 for musculoskeletal health. BPC-157 promotes collagen organization, fibroblast migration, and increased tensile strength in tendons, ligaments, and bone [L5]. Concurrently, TB-500 acts as a potent regulator of cell motility, ensuring that endothelial and progenitor cells are efficiently recruited to wound sites to drive tissue regeneration [L11]. This combination enhances angiogenesis through coordinated upregulation of VEGF and VEGFR2 [L4, L9], creating an optimal physiological environment for repairing damaged structural tissues.

Inflammation Resolution and Mucosal Healing

KPV serves as a critical bridge in the stack, providing superior mucosal healing and potent anti-inflammatory properties that complement the regenerative base. In the GI tract, KPV reduces colonic inflammation and improves mucosal integrity, which pairs effectively with BPC-157's gastrointestinal protective effects [L2, L6]. By inhibiting pro-inflammatory cytokines like TNF-α and IL-6 [L8], KPV mitigates the chronic inflammatory environment that often hinders effective repair, while TB-500 further minimizes the formation of fibrous scar tissue, ensuring that structural repair is functional rather than merely reparative [L9, L11].

Quick Reference

Member reference tables summarize the compound's research parameters.

Sign in to view this section

Research Indications

Gastrointestinal
Strong Evidence

Ulcer Protection

Studies demonstrate protective effects against gastric and duodenal ulcers through cytoprotective mechanisms.

Intestinal Repair

Research shows acceleration of intestinal healing and reduction of inflammatory markers in IBD models.

Mucosal Healing

Evidence supports enhanced mucosal barrier function and accelerated epithelial regeneration.

IBD Support

Shows promise for Crohn's disease and ulcerative colitis.

Intestinal Barrier

Helps repair and maintain gut barrier integrity.

Microbiome Balance

Selective antimicrobial effects preserve beneficial bacteria.

Wound Healing & Tissue Repair
Supported Research

Tendon Healing

Accelerated tendon-to-bone healing and improved biomechanical properties in injury models.

Muscle Regeneration

Accelerated healing of muscle fibers, reduced recovery time, and enhanced repair.

Angiogenesis

Promotes blood vessel formation and improves vascularization.

Ligament Healing

Promotes connective tissue repair and reduces scar formation.

Wound Closure

Enhanced dermal wound closure and improved overall healing outcomes.

Neurological
Preliminary Data

Neuroprotection

Protective effects against neuronal damage and neuroinflammation.

Spinal Cord Injury

Improved functional recovery and reduced tissue damage.

Peripheral Nerves

Enhanced peripheral nerve regeneration and functional recovery.

Brain Health

Supports neuroplasticity and protection against neurodegenerative processes.

Inflammation & Immunity
Preliminary Data

Systemic Inflammation

Reduces circulating inflammatory markers like TNF-α and IL-6.

Autoimmune Modulation

Helps balance overactive immune responses and cytokine production.

Joint Inflammation

Benefits for inflammatory arthritis.

Immune Balance

Helps shift from Th1/Th17 to regulatory T cell responses.

Athletic Recovery
Preliminary Data

Exercise Recovery

Faster recovery from intense training and reduced exercise-induced damage.

Injury Prevention

Strengthened connective tissues and improved resilience.

Research Protocols

As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.

This member section describes parameters reported in the research literature.

Sign in to view this section

Peptide Interactions

This member section summarizes reported compound interactions and evidence limitations.

Sign in to view this section

Reported Research Time Points

This member section summarizes reported research time points.

Sign in to view this section

Safety Notes

Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.

This member section discusses research safety considerations and uncertainties.

Sign in to view this section

Quality Indicators

Verified Marker

White, Fluffy Cake

Lyophilized powder should appear as a white/off-white cake. Proper freeze-drying results in a light, fluffy texture.

Verified Marker

Clear Solution After Reconstitution

When mixed with BAC water, the solution must be crystal clear with no particles, cloudiness, or precipitate.

Acceptable Range

Slight Clumping

Minor clumping due to shipping is acceptable if it dissolves completely with gentle swirling.

Quality Concern

Degradation Indicators

The listed research text specifies avoiding if powder is collapsed, melted, yellowed, or if reconstituted solution remains cloudy or contains particles.

Research Citations

Research Focus

tissueRepair, antiInflammatory, woundHealing, gutHealth, skinHealing

Verified Vendors Carrying BPC-157/TB-500/KPV (Phoenix)

Affiliate disclosure: we may earn a commission when you buy through links and codes on this page, at no extra cost to you.

See BPC-157/TB-500/KPV (Phoenix) vendors & sizes compared

Frequently Asked Questions

What is BPC-157/TB-500/KPV (Phoenix)?

The overview describes BPC-157/TB-500/KPV (Phoenix) as a three-peptide combination of BPC-157, TB-500, and KPV, a tripeptide derived from α-MSH. BPC-157 and TB-500 are grouped as the "Wolverine" stack, while KPV is added to broaden the focus to inflammation and mucosal healing. These roles are described as proposed mechanisms in research.

What has BPC-157/TB-500/KPV (Phoenix) been studied for?

The overview lists research areas for BPC-157/TB-500/KPV (Phoenix) including gastrointestinal protection, wound and tissue repair, neurological injury, inflammation and immunity, and athletic recovery. Examples include ulcer protection, tendon healing in injury models, spinal cord injury recovery, and cytokine markers. These are described as research topics, not established human outcomes.

How strong is the evidence for BPC-157/TB-500/KPV (Phoenix)?

The overview labels evidence differently by area for BPC-157/TB-500/KPV (Phoenix). Gastrointestinal research is labeled "Strong Evidence," wound healing and tissue repair "Supported Research," and neurological, inflammation and immunity, and athletic recovery topics "Preliminary Data." These are the overview's labels, and the overview does not present human trial results to establish benefits.

Related Compounds

Related Articles

Browse all peptides in the Encyclopedia →